Fulltext

Corrigendum to "Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer": [ESMO Open 9 (2024) 103647]

Chen LT 1 , Vogel A 2 , Hsu C 3 , Chen MH 4 , Fang W 5 , Pangarsa EA 6 Show all authors , Sharma A 7 , Ikeda M 8 , Park JO 9 , Tan CK 10 , Regala E 11 , Tai D 12 , Tanasanvimon S 13 , Charoentum C 14 , Chee CE 15 , Lui A 16 , Sow J 17 , Oh DY 18 , Ueno M 19 , Ramaswamy A 20 , Jeo WS 21 , Zhou J 22 , Curigliano G 23 , Yoshino T 24 , Bai LY 25 , Pentheroudakis G 26 , Chiang NJ 4 , Cervantes A 27 , Chen JS 28 , Ducreux M 29

Affiliations 

  • 1 Kaohsiung Medical University Hospital, Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan. Electronic address: leochen@nhri.org.tw
  • 2 Department of Gastroenterology, Hepatology and Endocrinology, Medical School of Hannover, Hannover, Germany; Division of Gastroenterology and Hepatology, Toronto General Hospital, Medical Oncology, Princess Margaret Cancer Centre, Toronto, Canada
  • 3 Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan
  • 4 Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan
  • 5 Department of Medical Oncology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
  • 6 Haematology Medical Oncology Division, Department of Oncology, Faculty of Medicine, Diponegoro University/Dr. Kariadi Hospital, Semarang, Indonesia
  • 7 Department of Medical Oncology, Max Institute of Cancer Care, Max Super Specialty Hospital, Saket, New Delhi, India
  • 8 Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan
  • 9 Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • 10 Department of Oncology and Nuclear Medicine, Thomson Hospital Kota Damansara, Petaling Jaya, Selangor, Malaysia
  • 11 Clinical Division Building, University of Santo Tomas Hospital, Sampaloc, Manila, Philippines
  • 12 Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore
  • 13 Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok
  • 14 Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
  • 15 Department of Haematology-Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore
  • 16 Department of Internal Medicine, Metro Davao Medical and Research Center, Davao City, The Philippines; Section of Medical Oncology, Department of Internal Medicine, Southern Philippines Medical Center, Davao City, The Philippines
  • 17 Department of Oncology, Curie Oncology Kuala Lumpur, Kuala Lumpur, Malaysia
  • 18 Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea
  • 19 Department of Gastroenterology, Kanagawa Cancer Center, Yokohama, Japan
  • 20 Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Parel, Mumbai, India
  • 21 Division of Digestive Surgery, Department of General Surgery, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia
  • 22 Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China
  • 23 Istituto Europeo di Oncologia, Milano, IRCCS, Milano, Italy; Department of Oncology and Haematology, University of Milano, Milano, Italy
  • 24 Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan
  • 25 Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, China Medical University, Taichung, Taiwan
  • 26 ESMO, Lugano, Switzerland
  • 27 Department of Medical Oncology, INCLIVA Biomedical Research Institute, University of Valencia, Valencia; CIBERONC. Instituto de Salud Carlos III, Madrid, Spain
  • 28 Department of Internal Medicine, Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan
  • 29 INSERM U1279, Université Paris-Saclay, Villejuif, France; Department of Cancer Medicine, Gustave Roussy, Villejuif, France
ESMO Open, 2025 Jan;10(1):104074.
PMID: 39864890 DOI: 10.1016/j.esmoop.2024.104074

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications